Regencell Bioscience Holdings Limited (RGC)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqCMHong KongKYG7487R1002
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Regencell Bioscience Holdings Limited, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:13. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 06 May 2027 17:00 | — | — | — | Upcoming |
| 28 Oct 2026 16:00 | — | — | — | — |
| 15 Jun 2026 16:00 | — | — | — | — |
| 18 Nov 2025 16:00 | — | — | — | — |
| 16 Jul 2025 16:00 | — | — | — | — |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 0 | — | -11.7M | — | — | — | -7.7M |
| 2025 | — | — | — | — | -0.01 | +17.2% | — |
| 2024 | 0 | — | -4.3M | — | -0.01 | +26.9% | -4M |
| 2023 | 0 | — | -5.9M | — | -0.01 | +22.0% | -5M |
| 2022 | 0 | — | -7.4M | — | -0.02 | — | -6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 5.36 | 5.73 | 4.89 | 4.98 | -5.54% | 606,303 | |
| 02 Nov 2026 – 06 Nov 2026 | 6.83 | 6.97 | 5.05 | 5.27 | -21.46% | 832,700 | |
| 26 Oct 2026 – 30 Oct 2026 | 7.76 | 7.89 | 6.50 | 6.71 | -12.52% | 1,202,500 | |
| 19 Oct 2026 – 23 Oct 2026 | 9.32 | 11.31 | 7.55 | 7.67 | -20.02% | 2,220,300 | |
| 12 Oct 2026 – 16 Oct 2026 | 7.23 | 11.12 | 6.82 | 9.59 | +30.48% | 3,959,600 | |
| 05 Oct 2026 – 09 Oct 2026 | 6.72 | 7.96 | 6.46 | 7.35 | +7.77% | 1,059,300 | |
| 28 Sep 2026 – 02 Oct 2026 | 6.15 | 7.39 | 6.05 | 6.82 | +10.53% | 679,000 | |
| 21 Sep 2026 – 25 Sep 2026 | 5.74 | 6.40 | 5.66 | 6.17 | +6.56% | 515,900 | |
| 14 Sep 2026 – 18 Sep 2026 | 5.63 | 6.10 | 5.48 | 5.79 | +2.66% | 439,400 | |
| 08 Sep 2026 – 11 Sep 2026 | 6.91 | 7.14 | 5.55 | 5.64 | -18.14% | 912,500 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Regencell Bioscience Holdings (RGC) Stock Looks Rich After A Very Large Run (opens in a new tab) Simply Wall St. · 10 Nov 2026 04:28
- Regencell (RGC) Stock Looks Rich As DOJ Probe Raises Questions (opens in a new tab) Simply Wall St. · 25 Oct 2026 08:10
- How Investors Are Reacting To Regencell Bioscience Holdings (RGC) Wider Full Year Loss (opens in a new tab) Simply Wall St. · 17 Oct 2026 16:10
- Is Regencell Bioscience Holdings (RGC) Fully Priced After Its Annual Loss Deepened? (opens in a new tab) Simply Wall St. · 08 Oct 2026 15:13
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 5.13 USD
- Market cap
- 2.5B
- Exchange
- NasdaqCM
- Country
- Hong Kong
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow RGC and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.